[Federal Register Volume 63, Number 71 (Tuesday, April 14, 1998)]
[Notices]
[Pages 18226-18227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-9825]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 3, 1997, and published in the Federal 
Register on December 19, 1997 (62 FR 66667), Ansys Diagnostics, Inc., 2 
Goodyear, Irvine, California 92718, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Phencyclidine (7471).......................  II                         
1-Piperidinocyclohexanecarbonitrile (PCC)    II                         
 (8603).                                                                
Benzoylecgonine (9180).....................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce

[[Page 18227]]

standards and controls for in-vitro diagnostic drug testing systems.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Ansys 
Diagnostics, Inc. to manufacture the listed controlled substances is 
consistent with the public interest at this time. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: April 3, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-9825 Filed 4-13-98; 8:45 am]
BILLING CODE 4410-09-M